The prevalence of allergic diseases has risen worldwide, especially among children and adolescents.
1,2 Great efforts have been dedicated to identifying factors associated with allergic disease,
3 and data have suggested associations between allergic diseases and acid-suppressive medication (ASM) use in fetal and early life.
4-8 Meanwhile, ASMs, including proton pump inhibitors (PPIs) and histamine 2 receptor antagonists (H2RAs), are frequently used during pregnancy to treat gastroesophageal reflux disease (GERD),
9 and in recent decades, the use of ASMs has substantially increased in both pregnant and pediatric populations.
10,11